Flu’s Evolution Strategy Strikes Perfect Balance
06/19
New therapeutic prospect: Tipping the balance to encourage flu death
|
Lonza Introduces Applied Protein Services Preclinical Platform To Improve Biologic Development Success
06/19
Basel, Switzerland, 10 June 2010 – Lonza, a leader in biopharmaceutical development services and contract manufacturing, is launching a new set of immunogenicity, stability and... |
Virus Infection May Trigger Unusual Immune Cells To Attack Nerves In Multiple Sclerosis
06/19
White blood cells with receptors for both virus and nerve proteins may assault nerves after fighting an infection
|
Microneedle Skin Patches Proven To Be At Least As Effective As Hypodermic Needles
06/19
|
2009 H1N1 Vaccine Protects Against 1918 Influenza Virus
06/19
Cross-protection helps alleviate bioterrorism concerns
|
NIH-Supported Experimental Marburg Vaccine Prevents Disease Two Days After Infection
06/19
An experimental vaccine developed to prevent outbreaks of Marburg hemorrhagic
fever continues to show promise in monkeys as an emergency treatment
for accidental... |
Plastic Antibody Works In First Tests In Living Animals
06/19
Scientists are reporting the first evidence that a plastic antibody — an artificial version of the proteins produced by the body's immune system to recognize and fight infections... |
How Bacteria Make Syringes
06/19
For a successful infection, bacteria must outwit the immune system of the host. To this aim, they deliver so-called virulence factors through a transport channel located in the... |
How Bacteria Boost the Immune System
06/19
Scientists have long known that certain types of bacteria boost the immune system. Now, Loyola University Health System researchers have discovered how bacteria perform this... |
New Promising Therapy Against Systemic Sclerosis
06/19
There is a new path to defeat systemic sclerosis, also called scleroderma because of the hardening of the skin of the patients (from Greek skleros, "hard", and derma, "skin")....
|
